With reference to its intimation bearing ref GTBL: CS: BSE-CORR/2021-22 dated 18th November, 2021. Gujarat Themis Biosyn has informed that the first page of transcript in the management details Company name- Gujarat Themis Biosyn has been inadvertently appeared after the name of Tushar Dalal and Sangameshwar Iyer and Compliance Officer after Sangameshwar Iyer. It has rectified the typographical error and no change except the first page. Hence, the company enclosed the Earnings Call Transcript pertaining to 02 and H1 of FY22 Financial Results of the Company with the rectified first page. The aforesaid information is also being made available on the website of the Company at www.gtbl.in.
The above information is a part of company’s filings submitted to BSE.
| Company Name | CMP |
|---|---|
| Sun Pharma Inds. | 1675.20 |
| Dr. Reddys Lab | 1235.40 |
| Cipla | 1238.30 |
| Zydus Lifesciences | 942.55 |
| Lupin | 2324.25 |
| View more.. | |
MoneyWorks4Me is a SEBI-registered Investment Adviser (IA) dedicated to helping investors build long-term wealth through transparent, research-driven, conflict-free guidance. Founded in 2008, we started our journey as a Research Analyst (RA), providing deep fundamental analysis, intrinsic value insights, and long-term investing frameworks for Indian equities. In 2017, we transitioned to a full-fledged SEBI-registered Investment Adviser, strengthening our commitment to acting as a fiduciary—always putting the investor’s interest first.
To become India’s most trusted, research-powered fiduciary advisory platform—where every investor, regardless of experience, can make calm, confident, and well-reasoned investment decisions.
MoneyWorks4Me ensures this through: